Hematos IIG Certified by the Saudi Food & Drug Authority
The blood supply chain management software has obtained the Medical Device Marketing Authorization (MDMA)
We are pleased to announce that Hematos IIG, the blood supply chain management software by Gpi France, has received Medical Device Marketing Authorization (MDMA) from the Saudi Food & Drug Authority (SFDA).
This certification, valid until 2028, confirms the robustness of our production process and full compliance with the highest standards in the healthcare sector, ensuring maximum safety for both patients and healthcare professionals. With over 250 hospitals already using our solutions in Saudi Arabia, Gpi further strengthens its presence in the country, reinforcing its international expansion strategy through rigorous validation procedures designed to minimize risks.
As part of the Gpi4Med.BLOOD Suite, Hematos IIG continues to stand out as a safe and innovative solution, capable of effectively responding to the evolving needs of the healthcare market.
